Vuno Inc

Vuno Inc's capital structure shows a debt-to-equity ratio of 0.21, indicating a conservative leverage profile. The company holds 5.55 billion KRW in cash and equivalents but has a negative free cash flow of -5.31 billion KRW, suggesting ongoing operational cash burn. The current ratio of 3.05 implies strong short-term liquidity, though operating cash flow is negative at -4.68 billion KRW. Profitability metrics are weak, with a return on equity of -16% and return on assets of -11.47%. Gross profit of 33.97 billion KRW is high relative to revenue of 34.85 billion KRW, but operating and net losses of -4.93 billion and -5.78 billion KRW, respectively, indicate significant cost overruns or underperformance in converting gross profit to net income. The company's geographic exposure is not explicitly quantified in the input data, but disclosed markets include Japan, Europe, and the United States. Revenue concentration by segment is also not provided, though the product portfolio spans imaging, pathology, biosignal, and voice technologies. The absence of segment-specific revenue data limits visibility into concentration risk. Growth trajectory is unclear due to the lack of historical revenue data, but the current FY outlook is not provided. The company's negative operating and net income suggest a focus on R&D and market expansion rather than immediate profitability. Analysts have assigned a mean recommendation of 1.00 (strong buy), with one strong-buy rating and no buy/hold/sell ratings, indicating optimism about long-term potential despite current losses. Risk factors include medium liquidity risk due to negative free cash flow and operating cash flow, though the current ratio remains strong. Dilution risk is assessed as low, with no near-term pressure indicated. The company's negative net cash position after subtracting total debt raises concerns about its ability to fund operations without external financing. Recent events include a strong-buy analyst rating and a negative EPS actual of -413 KRW compared to a mean estimate of 278 KRW, highlighting the gap between expectations and performance. No recent filings or transcripts are provided in the input data to further contextualize these results.